Clinical Trial Update: Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis

View source ↗

Summary

Clinical trial update examining the risk of coccidioidomycosis in patients with inflammatory arthritis treated with anti-TNF and other biologic agents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coccidioidomycosis
• Rheumatoid Arthritis

Snippet

Sponsor: University of Arizona | Conditions: Coccidioidomycosis, Rheumatoid Arthritis | Status: COMPLETED